BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 9409568)

  • 1. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.
    Majno PE; Adam R; Bismuth H; Castaing D; Ariche A; Krissat J; Perrin H; Azoulay D
    Ann Surg; 1997 Dec; 226(6):688-701; discussion 701-3. PubMed ID: 9409568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TACE: therapy of the HCC before liver transplantation--experiences].
    Herber S; Schneider J; Brecher B; Höhler T; Thelen M; Otto G; Pitton MB
    Rofo; 2005 May; 177(5):681-90. PubMed ID: 15871083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
    Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?
    Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
    World J Surg; 2007 Dec; 31(12):2370-7. PubMed ID: 17912587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
    Herber S; Biesterfeld S; Franz U; Schneider J; Thies J; Schuchmann M; Düber C; Pitton MB; Otto G
    Cardiovasc Intervent Radiol; 2008; 31(4):768-77. PubMed ID: 18196335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.
    Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma.
    Hołówko W; Wróblewski T; Wojtaszek M; Grąt M; Kobryń K; Ziarkiewicz-Wróblewska B; Krawczyk M
    Ann Transplant; 2015 Dec; 20():764-8. PubMed ID: 26712800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
    Allard MA; Sebagh M; Ruiz A; Guettier C; Paule B; Vibert E; Cunha AS; Cherqui D; Samuel D; Bismuth H; Castaing D; Adam R
    J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of surgical resection for multiple hepatocellular carcinomas.
    Choi SH; Choi GH; Kim SU; Park JY; Joo DJ; Ju MK; Kim MS; Choi JS; Han KH; Kim SI
    World J Gastroenterol; 2013 Jan; 19(3):366-74. PubMed ID: 23372359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
    J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.
    Cascales Campos P; Ramirez P; Gonzalez R; Febrero B; Pons JA; Miras M; Sanchez Bueno F; Robles R; Parrilla P
    Transplant Proc; 2011; 43(6):2213-5. PubMed ID: 21839236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients.
    Hayashi K; Ina H; Tezuka M; Okada Y; Irie T
    Cardiovasc Intervent Radiol; 2007; 30(6):1144-55. PubMed ID: 17909884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.